Germany
Japan
United Kingdom
China
ALK mouse monoclonal antibody, clone OTI1A4
| Applications | IHC, LMNX, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
.jpg?d=110x100 "User supplied image")
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal IRS-1 (Ab-312) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human IRS-1 around the phosphorylation site of serine 312 (A-T-SP-P-A). |
Goat Polyclonal Anti-HTT Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 85 to 200 aa of human HTT produced in E. coli |
Rabbit polyclonal IRF-3 (Ser385) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human IRF-3 around the phosphorylation site of serine 385 (G-A-SP-S-L). |
| Modifications | Phospho-specific |
Rabbit anti-STAT3 (Phospho-Tyr705) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanSTAT3 around the phosphorylation site of tyrosine 705 (A-P-YP-L-K). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-Cathepsin D Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 275 aa to the C-terminus of human Cathepsin D produced in E. coli. |
Rabbit polyclonal Syndecan4 (Ab-179) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Syndecan4 around the phosphorylation site of serine 179 (E-G-SP-Y-D). |
Rabbit Polyclonal antibody to RAC1 (ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1))
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 1 and 196 of RAC1 (Uniprot ID#P63000 isoform B) |
Rabbit polyclonal IL1R Antibody (C-term E487)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This IL1R antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 474-503 amino acids from the C-terminal region of human IL1R. |
Goat Polyclonal Anti-Cathepsin D Antibody
| Applications | IF, IHC, WB |
| Reactivities | Canine, Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from within residues 275 aa to the C-terminus of human Cathepsin D produced in E. coli. |
Rabbit polyclonal GR (Ab-211) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GR around the phosphorylation site of serine 211 (N-E-S-P-W). |
Rabbit polyclonal GRB2 (Ab-159) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human GRB2 around the phosphorylation site of serine 159 (K-S-SP-A-P). |
Rabbit polyclonal Catenin-beta (Tyr489) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Catenin-β around the phosphorylation site of tyrosine 489 (L-H-YP-G-L). |
| Modifications | Phospho-specific |
Carrier-free (BSA/glycerol-free) PAK4 mouse monoclonal antibody, clone OTI1C7 (formerly 1C7)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-AOX1 rabbit polyclonal antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 300 amino acids of human aldehyde oxidase 1 |
Anti-KLK5 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 279-293 amino acids of Human kallikrein-related peptidase 5 |
Anti-PAK7 Rabbit Polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to C terminal 300 amino acids of human p21 protein (Cdc42/Rac)-activated kinase 7p21 protein (Cdc42/Rac)-activated kinase 7 |
Anti-CEBPA Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 82-100 amino acids of Human CCAAT/enhancer binding protein (C/EBP), alpha |
Anti-BID Rabbit Polyclonal Antibody
| Applications | ELISA, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Full length fusion protein |
Anti-NLRP3 Rabbit Polyclonal Antibody
| Applications | ELISA, IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Fusion protein corresponding to a region derived from 1-301 amino acids of human NLR family, pyrin domain containing 3 |
Anti-GAS6 Rabbit Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Synthetic peptide corresponding to a region derived from 690-705 amino acids of Human growth arrest-specific 6 |
Active filters
Category
-
Antibodies
- Primary Antibodies
Reactivities
- Rat
Applications
- IHC
Families
- Druggable Genome
Citations
- Yes
Availabilities
- In Stock
Filter by
Target Symbol
- LGR5 (6)
- CDH2 (4)
- CTNNB1 (4)
- ALDH1A3 (3)
- ALK (3)
- BAX (3)
- ERBB2 (3)
- GBE1 (3)
- KRT8 (3)
- MAPK1 (3)
- MME (3)
- NR4A3 (3)
- PDE10A (3)
- SLC7A8 (3)
- SNAI2 (3)
- UNG (3)
- ABCD1 (2)
- ACTN1 (2)
- ADH1B (2)
- ANXA1 (2)
- AQP1 (2)
- ARNT (2)
- BCL2 (2)
- BCL2L1 (2)
- BECN1 (2)
- BTK (2)
- CAT (2)
- CTSD (2)
- CYP2B6 (2)
- DCK (2)
- DPP4 (2)
- DPP8 (2)
- EGR2 (2)
- ETS2 (2)
- FGF2 (2)
- FGFR2 (2)
- FOSL1 (2)
- L1CAM (2)
- LIMK1 (2)
- LTA4H (2)
- MAP2K1 (2)
- NCAM1 (2)
- NME1 (2)
- NOTCH1 (2)
- NPR3 (2)
- NRAS (2)
- NTF3 (2)
- NTRK1 (2)
- NTRK2 (2)
- PARP1 (2)
- POSTN (2)
- PPAT (2)
- PRKAR1A (2)
- PTCH1 (2)
- RAB27A (2)
- RELA (2)
- RGS5 (2)
- SDCBP (2)
- SERPINB1 (2)
- SH3GL1 (2)
- STAT3 (2)
- TUBB1 (2)
- XRCC1 (2)
- ZEB2 (2)
- ABCC4 (1)
- AGL (1)
- AKT1 (1)
- AKT3 (1)
- ALDH1L1 (1)
- ANPEP (1)
- ANTXR1 (1)
- AOX1 (1)
- ARNTL (1)
- ASS1 (1)
- BAG3 (1)
- BID (1)
- BMP4 (1)
- CASP3 (1)
- CCNE1 (1)
- CDK6 (1)
- CDX2 (1)
- CEBPA (1)
- CMPK1 (1)
- COPS6 (1)
- CYP19A1 (1)
- CYP2A6 (1)
- CYP3A4 (1)
- DES (1)
- EGFR (1)
- EPAS1 (1)
- ERCC4 (1)
- ESR1 (1)
- EZH2 (1)
- FBXW7 (1)
- FGFR3 (1)
- FMR1 (1)
- FN1 (1)
- FTH1 (1)
- GAB2 (1)
- GAD1 (1)
Antibody Hosts
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (60)
- Metabolic pathways (36)
- Focal adhesion (31)
- MAPK signaling pathway (31)
- Neurotrophin signaling pathway (27)
- Prostate cancer (27)
- Regulation of actin cytoskeleton (25)
- Adherens junction (23)
- Colorectal cancer (23)
- Pancreatic cancer (22)
- Renal cell carcinoma (20)
- Apoptosis (19)
- Endometrial cancer (19)
- ErbB signaling pathway (19)
- Chronic myeloid leukemia (18)
- Chemokine signaling pathway (17)
- Axon guidance (16)
- Melanoma (16)
- T cell receptor signaling pathway (16)
- Acute myeloid leukemia (15)
- B cell receptor signaling pathway (15)
- Insulin signaling pathway (15)
- Non-small cell lung cancer (15)
- Bladder cancer (14)
- Fc epsilon RI signaling pathway (14)
- Glioma (14)
- Progesterone-mediated oocyte maturation (14)
- Small cell lung cancer (14)
- Thyroid cancer (14)
- VEGF signaling pathway (14)
- Endocytosis (13)
- Gap junction (13)
- Prion diseases (13)
- Tight junction (13)
- Toll-like receptor signaling pathway (13)
- Amyotrophic lateral sclerosis (ALS) (12)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (12)
- Fc gamma R-mediated phagocytosis (12)
- Melanogenesis (12)
- Natural killer cell mediated cytotoxicity (12)
- Alzheimer's disease (11)
- Cell adhesion molecules (CAMs) (11)
- Dorso-ventral axis formation (11)
- Purine metabolism (11)
- Drug metabolism - cytochrome P450 (10)
- GnRH signaling pathway (10)
- Leukocyte transendothelial migration (10)
- Adipocytokine signaling pathway (9)
- Huntington's disease (8)
- Jak-STAT signaling pathway (8)
- Long-term depression (8)
- Long-term potentiation (8)
- Metabolism of xenobiotics by cytochrome P450 (8)
- NOD-like receptor signaling pathway (8)
- Pathogenic Escherichia coli infection (8)
- p53 signaling pathway (8)
- Basal cell carcinoma (7)
- Base excision repair (7)
- Epithelial cell signaling in Helicobacter pylori infection (7)
- Oocyte meiosis (7)
- TGF-beta signaling pathway (7)
- Wnt signaling pathway (7)
- Arachidonic acid metabolism (6)
- Glycolysis / Gluconeogenesis (6)
- Pyrimidine metabolism (6)
- Retinol metabolism (6)
- Type II diabetes mellitus (6)
- Tyrosine metabolism (6)
- Vascular smooth muscle contraction (6)
- mTOR signaling pathway (6)
- Cytokine-cytokine receptor interaction (5)
- Hematopoietic cell lineage (5)
- Primary immunodeficiency (5)
- Viral myocarditis (5)
- Alanine (4)
- Calcium signaling pathway (4)
- Renin-angiotensin system (4)
- Starch and sucrose metabolism (4)
- Ubiquitin mediated proteolysis (4)
- aspartate and glutamate metabolism (4)
- ABC transporters (3)
- Cytosolic DNA-sensing pathway (3)
- Dilated cardiomyopathy (3)
- ECM-receptor interaction (3)
- Hedgehog signaling pathway (3)
- Histidine metabolism (3)
- Hypertrophic cardiomyopathy (HCM) (3)
- Lysosome (3)
- Parkinson's disease (3)
- Phenylalanine metabolism (3)
- RIG-I-like receptor signaling pathway (3)
- Tryptophan metabolism (3)
- Type I diabetes mellitus (3)
- Antigen processing and presentation (2)
- Cardiac muscle contraction (2)
- Cell cycle (2)
- Drug metabolism - other enzymes (2)
- Fatty acid metabolism (2)
- Fructose and mannose metabolism (2)
- Inositol phosphate metabolism (2)
- Methane metabolism (2)
- Neuroactive ligand-receptor interaction (2)
- Notch signaling pathway (2)
- One carbon pool by folate (2)
- Oxidative phosphorylation (2)
- Phosphatidylinositol signaling system (2)
- Regulation of autophagy (2)
- SNARE interactions in vesicular transport (2)
- Systemic lupus erythematosus (2)
- Vibrio cholerae infection (2)
- Allograft rejection (1)
- Androgen and estrogen metabolism (1)
- Arginine and proline metabolism (1)
- Autoimmune thyroid disease (1)
- Butanoate metabolism (1)
- Caffeine metabolism (1)
- Circadian rhythm - mammal (1)
- Citrate cycle (TCA cycle) (1)
- Galactose metabolism (1)
- Glutathione metabolism (1)
- Glycerophospholipid metabolism (1)
- Graft-versus-host disease (1)
- Linoleic acid metabolism (1)
- Mismatch repair (1)
- Nicotinate and nicotinamide metabolism (1)
- Nucleotide excision repair (1)
- Other glycan degradation (1)
- Pantothenate and CoA biosynthesis (1)
- Pentose phosphate pathway (1)
- Porphyrin and chlorophyll metabolism (1)
- Primary bile acid biosynthesis (1)
- RNA degradation (1)
- Sphingolipid metabolism (1)
- Spliceosome (1)
- Taurine and hypotaurine metabolism (1)
- Valine (1)
- Vitamin B6 metabolism (1)
- beta-Alanine metabolism (1)
- leucine and isoleucine degradation (1)